Vicarious Surgical (RBOTW) Amortization of Deferred Charges (2021 - 2022)
Vicarious Surgical (RBOTW) reported Amortization of Deferred Charges of $50000.0 for Q4 2022, up 433.33% year-over-year from $9375.0 in Q4 2021, and up 525.0% on a QoQ basis from $8000.0 in Q3 2022.
Vicarious Surgical (RBOTW) has 2 years of Amortization of Deferred Charges data on file, last reported at $50000.0 in Q4 2022.
- Quarterly Amortization of Deferred Charges rose 433.33% year-over-year to $50000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $75000.0 (changed N/A YoY) and the FY2022 annual result came in at $75000.0, up 257.14% from the prior year.
- Amortization of Deferred Charges grew to $50000.0 in Q4 2022 per RBOTW's latest filing, from $8000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $50000.0 in Q4 2022 and bottomed at -$15000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Sep 30, 2021 | 27,000.00 |